Incorporating sTILs Into PREDICT Substantially Improves the Model’s Ability to Distinguish High- and Low-Risk Patients with TNBC By Ogkologos - May 5, 2026 189 0 Facebook Twitter Google+ Pinterest WhatsApp Building the PREDICT_sTILs prognostication model Source RELATED ARTICLESMORE FROM AUTHOR Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years for Patients with Metastatic Hormone-Sensitive Prostate Cancer Metastatic Breast Cancer: ESMO Living Guideline EMA Recommends Extension of Indications for Datopotamab Deruxtecan MOST POPULAR Divarasib in Combination with Cetuximab Demonstrates a Manageable Safety Profile and... December 20, 2023 Better together: improving brain tumour treatment February 13, 2023 Combination Chemo Helps People with Leiomyosarcoma Live Longer October 2, 2024 FDA Approves Nivolumab for Adjuvant Treatment of Urothelial Carcinoma August 24, 2021 Load more HOT NEWS FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer New plan unveiled to tackle Scotland’s cancer crisis FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma That Cancer Conversation is back!
